NPPA Compliance Services in India
The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of pharmaceutical products in India under the Drug Prices Control Order (DPCO), 2013. Compliance with NPPA pricing regulations is mandatory for all pharmaceutical companies manufacturing, importing, or marketing drugs in India — particularly those listed under the National List of Essential Medicines (NLEM).
NPPA compliance is complex, with ceiling prices updated regularly and strict penalties for overcharging. ACPL provides expert NPPA compliance consulting to help pharmaceutical companies navigate pricing regulations while maintaining profitability.
Our Services
- DPCO compliance review and advisory
- Ceiling price calculations and filings
- National List of Essential Medicines (NLEM) compliance assessment
- Price increase notifications and applications (annual WPI-based adjustments)
- Annual price revision filings and documentation
- NPPA query responses and regulatory liaison
- Overcharging notice defence and penalty mitigation
- New product pricing strategy under DPCO framework
Key DPCO Provisions
- Scheduled formulations — Ceiling prices fixed by NPPA for all drugs on the NLEM; manufacturers cannot charge above the ceiling price plus 16% retailer margin
- Non-scheduled formulations — Annual price increase capped at 10% above previous year’s MRP
- New drugs — Pricing governed by market-based mechanisms for the first five years
- Patented drugs — Subject to compulsory licensing provisions under specific circumstances
Penalties for Non-Compliance
NPPA actively monitors drug prices and issues demand notices for overcharging. Penalties include recovery of overcharged amounts with interest at 15% per annum from the date of overcharging, plus potential prosecution under the Essential Commodities Act.
Related Services
- CDSCO Registration — Drug registration triggering NPPA pricing obligations
- Pharmacovigilance — Post-market safety requirements alongside pricing compliance
- DSIR Recognition — R&D tax benefits for pharmaceutical companies
- DGFT Approvals — Import-export compliance for pharmaceutical trade